248 related articles for article (PubMed ID: 7505277)
1. Alterations in the cyclic AMP signal transduction pathway regulating ribonucleotide reductase gene expression in malignant H-ras transformed cell lines.
Hurta RA; Wright JA
J Cell Physiol; 1994 Jan; 158(1):187-97. PubMed ID: 7505277
[TBL] [Abstract][Full Text] [Related]
2. Ornithine decarboxylase gene expression is aberrantly regulated via the cAMP signal transduction pathway in malignant H-ras transformed cell lines.
Hurta RA; Wright JA
J Cell Physiol; 1994 Nov; 161(2):383-91. PubMed ID: 7525612
[TBL] [Abstract][Full Text] [Related]
3. Malignant transformation by H-ras results in aberrant regulation of ribonucleotide reductase gene expression by transforming growth factor-beta 1.
Hurta RA; Wright JA
J Cell Biochem; 1995 Mar; 57(3):543-56. PubMed ID: 7768988
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta 1 mediated alterations in ribonucleotide reductase gene expression in BALB/c 3T3 fibroblasts.
Hurta RA; Greenberg AH; Wright JA
J Cell Physiol; 1992 Sep; 152(3):529-35. PubMed ID: 1506411
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta1 selectively regulates ferritin gene expression in malignant H-ras-transformed fibrosarcoma cell lines.
Lo J; Hurta RA
Biochem Cell Biol; 2000; 78(4):527-35. PubMed ID: 11012093
[TBL] [Abstract][Full Text] [Related]
6. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
Voskas D; Mader R; Lee J; Hurta RA
Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
[TBL] [Abstract][Full Text] [Related]
7. Cellular signaling pathways affect the function of ribonucleotide reductase mRNA binding proteins: mRNA stabilization, drug resistance, and malignancy (Review).
Burton TR; Kashour T; Wright JA; Amara FM
Int J Oncol; 2003 Jan; 22(1):21-31. PubMed ID: 12469181
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta 1 selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed fibrosarcoma cell lines.
Hurta RA; Greenberg AH; Wright JA
J Cell Physiol; 1993 Aug; 156(2):272-9. PubMed ID: 8344985
[TBL] [Abstract][Full Text] [Related]
9. Suppression of malignancy by the 3' untranslated regions of ribonucleotide reductase R1 and R2 messenger RNAs.
Fan H; Villegas C; Huang A; Wright JA
Cancer Res; 1996 Oct; 56(19):4366-9. PubMed ID: 8813126
[TBL] [Abstract][Full Text] [Related]
10. Norepinephrine specifically stimulates ribonucleotide reductase subunit R2 gene expression in proliferating brown adipocytes: mediation via a cAMP/PKA pathway involving Src and Erk1/2 kinases.
Fredriksson JM; Nedergaard J
Exp Cell Res; 2002 Apr; 274(2):207-15. PubMed ID: 11900481
[TBL] [Abstract][Full Text] [Related]
11. Opposite effects of cyclic AMP on the expression of the genes encoding ribonucleotide reductase in Swiss 3T3 and RAT 1 cells.
Albert DA; Rozengurt E
Biochem Biophys Res Commun; 1993 Oct; 196(2):642-9. PubMed ID: 7694574
[TBL] [Abstract][Full Text] [Related]
12. Altered regulation of message stability and tumor promoter-responsive cis-trans interactions of ribonucleotide reductase R1 and R2 messenger RNAs in hydroxyurea-resistant cells.
Amara FM; Hurta RA; Huang A; Wright JA
Cancer Res; 1995 Oct; 55(20):4503-6. PubMed ID: 7553616
[TBL] [Abstract][Full Text] [Related]
13. S-Adenosylmethionine decarboxylase gene expression is regulated by the cAMP signal transduction pathway in H-ras transformed fibrosarcoma cells capable of malignant progression.
Hurta RA
J Cell Biochem Suppl; 2001; Suppl 36():209-21. PubMed ID: 11455586
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated ribonucleotide reductase R1 gene therapy of human colon adenocarcinoma.
Cao MY; Lee Y; Feng NP; Xiong K; Jin H; Wang M; Vassilakos A; Viau S; Wright JA; Young AH
Clin Cancer Res; 2003 Oct; 9(12):4553-61. PubMed ID: 14555530
[TBL] [Abstract][Full Text] [Related]
15. Effect of cyclic AMP on the cell cycle regulation of ribonucleotide reductase M2 subunit messenger RNA concentrations in wild-type and mutant S49 T lymphoma cells.
Albert DA; Nodzenski E; Yim G; Kowalski J
J Cell Physiol; 1990 May; 143(2):251-6. PubMed ID: 2159014
[TBL] [Abstract][Full Text] [Related]
16. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
Hurta RA; Lee J; Voskas D
J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396
[TBL] [Abstract][Full Text] [Related]
17. Expression of hepatocyte growth factor is up-regulated through activation of a cAMP-mediated pathway.
Matsunaga T; Gohda E; Takebe T; Wu YL; Iwao M; Kataoka H; Yamamoto I
Exp Cell Res; 1994 Feb; 210(2):326-35. PubMed ID: 7507855
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations.
Choy BK; McClarty GA; Chan AK; Thelander L; Wright JA
Cancer Res; 1988 Apr; 48(8):2029-35. PubMed ID: 2832057
[TBL] [Abstract][Full Text] [Related]
19. Human R1 subunit of ribonucleotide reductase (RRM1): 5' flanking region of the gene.
Parker NJ; Begley CG; Fox RM
Genomics; 1994 Jan; 19(1):91-6. PubMed ID: 8188248
[TBL] [Abstract][Full Text] [Related]
20. Multiple synergistic signal transduction pathways regulate c-fos expression in Swiss 3T3 cells: the role of cyclic AMP.
Mehmet H; Morris C; Rozengurt E
Cell Growth Differ; 1990 Jun; 1(6):293-8. PubMed ID: 1703775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
